In our soon-to-launch video series “The More You Know”, movement disorder specialists sit down with us on video to explain each FDA approved Parkinson’s medication and surgical treatment. In this series we ask the question, “What do you tell a patient when you prescribe this treatment?”
This week neurologist Mindy Bixby, DO of the Parkinson’s Disease and Movement Disorder Center at Scripps Clinic in San Diego, CA takes a deeper look at Mirapex, generic name pramipexole. Mirapex is in a class of Parkinson’s drugs called dopamine agonists. Dopamine agonists sit on the same receptors as dopamine, and while they are chemically different from dopamine, they essentially do the same job. They can have serious side effects in some people, but are an important option in a medication regimen. Hear more straight from Dr. Bixby by clicking the below video.
Mindy Bixby, DO, is a neurologist and movement disorder specialist who cares for patients at all levels of neurological disease. She uses a multidisciplinary approach that includes medical management and physical, occupational, and speech therapies. Dr. Bixby is affiliated with the Parkinson’s and Movement Disorder Institute in Fountain Valley, CA and treats patients with a wide range of neurological diseases. She has a special interest in movement disorders, Parkinson’s, essential tremor, atypical Parkinson’s, dystonia, ataxia, and spasticity. Dr. Bixby received her Doctorate of Osteopathy from Touro University College of Osteopathic Medicine in California. She completed her residency in neurology at Georgetown University Hospital in Washington, DC. Dr. Bixby remained at Georgetown-National Rehabilitation Hospital for her fellowship in Neurorehabilitation and completed a second fellowship in Movement Disorders at Georgetown University Hospital. Dr. Bixby has received intensive training in deep brain stimulation, botulinum toxin injections, and the medical management of Parkinson’s disease and related movement disorders.